Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy

被引：0
|
作者：
Wei Chen
Shuifang Hu
Zelong Liu
Yukun Sun
Jian Wu
Shunli Shen
Zhenwei Peng
机构：
[1] The First Affiliated Hospital of Sun Yat-Sen University,Center of Hepato
[2] The First Affiliated Hospital of Sun Yat-Sen University,Pancreato
[3] The First Affiliated Hospital of Sun Yat-Sen University, Biliary Surgery
[4] The First Affiliated Hospital of Sun Yat-Sen University,Department of Pancreaticobiliary Surgery
[5] The First Affiliated Hospital of Sun Yat-Sen University,Department of Radiation Oncology
[6] The First Affiliated Hospital of Sun Yat-Sen University,Department of Liver Surgery
[7] The First Affiliated Hospital of Sun Yat-Sen University,Institute of Precision Medicine
来源：
Hepatology International | 2023年 / 17卷
关键词：
Hepatocellular carcinoma; Hepatic venous tumor thrombus; Independent prognostic factors; Overall survival; Postoperative adjuvant therapy; Portal venous tumor thrombus; Programmed cell death 1; Propensity-score matching; Recurrence; Recurrence-free survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：406 / 416
页数：10
相关论文
共 50 条
  • [21] Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma
    Alden, Stephanie L.
    Lim, Mir
    Kao, Chester
    Shu, Daniel
    Singal, Amit G.
    Noonan, Anne
    Griffith, Paige
    Baretti, Marina
    Ho, Won Jin
    Kamel, Ihab
    Yarchoan, Mark
    Hsiehchen, David
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (07): : 1312 - 1317
  • [22] Recurrence of Hepatocellular Carcinoma in Noncirrhotic Liver After Hepatectomy
    Chiche, Laurence
    Menahem, B.
    Bazille, C.
    Bouvier, V.
    Plard, L.
    Saguet, V.
    Alves, A.
    Salame, E.
    WORLD JOURNAL OF SURGERY, 2013, 37 (10) : 2410 - 2418
  • [23] Recurrence of Hepatocellular Carcinoma in Noncirrhotic Liver After Hepatectomy
    Laurence Chiche
    B. Menahem
    C. Bazille
    V. Bouvier
    L. Plard
    V. Saguet
    A. Alves
    E. Salame
    World Journal of Surgery, 2013, 37 : 2410 - 2418
  • [24] Treatment of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma
    Matsumoto, Michinori
    Yanaga, Katsuhiko
    Shiba, Hiroaki
    Wakiyama, Shigeki
    Sakamoto, Taro
    Futagawa, Yasuro
    Gocho, Takeshi
    Ishida, Yuichi
    Ikegami, Toru
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2021, 5 (04): : 538 - 552
  • [25] Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations
    Zhu, Xiao-Dong
    Huang, Cheng
    Shen, Ying-Hao
    Ji, Yuan
    Ge, Ning-Ling
    Qu, Xu-Dong
    Chen, Lingli
    Shi, Wen-Kai
    Li, Mei-Ling
    Zhu, Jin-Jin
    Tan, Chang-Jun
    Tang, Zhao-You
    Zhou, Jian
    Fan, Jia
    Sun, Hui-Chuan
    LIVER CANCER, 2021, 10 (04) : 320 - 329
  • [26] Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody
    Akce, Mehmet
    Liu, Yuan
    Zakka, Katerina
    Martini, Dylan J.
    Draper, Amber
    Alese, Olatunji B.
    Shaib, Walid L.
    Wu, Christina
    Wedd, Joel P.
    Sellers, Marty T.
    Bilen, Mehmet A.
    El-Rayes, Bassel F.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (02): : 74 - 81
  • [27] Hepatectomy After Conversion Therapy with Hepatic Arterial Infusion Chemotherapy, Tyrosine Kinase Inhibitors and Anti-PD-1 Antibodies for Initially Unresectable Hepatocellular Carcinoma
    Yu, Bingran
    Zhang, Ning
    Feng, Yun
    Zhang, Yongfa
    Zhang, Ti
    Wang, Lu
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 1709 - 1721
  • [28] Combination activity of eribulin liposomal formulation and anti-PD-1 antibody after tumor regrowth during anti-PD-1 antibody treatment in mice
    Tamura, Moe
    Niwa, Yuki
    Semba, Taro
    CANCER RESEARCH, 2024, 84 (06)
  • [29] A multicenter, randomized, controlled, phase II trial exploring adjuvant combined therapy of apatinib and SHR-1210 (anti-PD-1), in patients with hepatocellular carcinoma at high risk of recurrence after radical resection
    Yan, S.
    Zhang, Y.
    Bi, X.
    Zhao, J.
    Du, S.
    Huang, Z.
    Zhang, Y.
    Liu, D.
    Li, Z.
    Zhou, J.
    Cai, J.
    Zhao, H.
    ANNALS OF ONCOLOGY, 2019, 30
  • [30] Novel RNA-nanoparticle vaccine for the treatment of early melanoma recurrence following adjuvant anti-PD-1 antibody therapy
    Doonan, Bently Patrick
    Shaw, Christiana M.
    Lee, Ji-Hyun
    Manso, Eugenio Simon
    Mendez-Gomez, Hector
    Von Roemeling, Christina
    Mitchell, Duane Anthony
    Sayour, Elias
    George, Thomas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345